Micrus reports on aneurysm trial for MicroCoil:
This article was originally published in Clinica
Micrus has presented trial data on 120 intracranial aneurysms embolised using its minimally invasive ACT MicroCoil system. The product, which employs a heat resistive detachment system, was reported to be quick, effective and reliable in treating intracerebral aneurysms - principally wide neck lesions. The MicroCoil was used to treat patients with a wide variety of aneurysms and procedures done in both the anterior and posterior circulation of the brain were successful, said the Mountain View, California firm. The MicroCoil system gained US FDA and CE-mark approvals for sale last year.
You may also be interested in...
Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.
Through a draft guidance, the US agency has established performance criteria for magnetic resonance coils, making the devices eligible for the standards-based Safety and Performance Based Pathway.
Singapore recalls trigger international reaction as metformin is added to growing list of chronic medications found to contain NDMA.